Distinct DNA damage determines differential phosphorylation of Chk2

Area of Science:

• Cellular biology
• Molecular oncology
• DNA damage response

Background:

• Checkpoint kinase 2 (Chk2) is a key player in cellular responses to DNA damage.
• Understanding Chk2 phosphorylation dynamics is crucial for elucidating DNA repair pathways.

Purpose of the Study:

• To investigate the detailed phosphorylation kinetics of Chk2 upon exposure to different DNA-damaging agents.
• To determine the role of ATM (Ataxia-telangiectasia mutated) in Chk2 phosphorylation.
• To explore how specific Chk2 phosphorylation sites are regulated by DNA damage.

Main Methods:

• Utilized human fibroblast (BJ) and colorectal cancer (HCT116) and cervical cancer (HeLa) cell lines.
• Treated cells with neocarzinostatin (NCS) or doxorubicin (Dox) to induce DNA damage.
• Employed Chk2-deficient cells re-expressing phospho-mutant Chk2 (T68A) and ATM-deficient fibroblasts.

Main Results:

• NCS treatment rapidly induced Chk2 Thr68 phosphorylation, followed by Ser19 and Ser33/35.
• ATM is essential for NCS-induced phosphorylation of NBS1 Ser343 and Chk2 Ser19/Ser33/35, but not Thr68.
• Inhibition of Thr68 phosphorylation enhanced Ser19 phosphorylation in NCS-treated cells.
• Doxorubicin induced sustained Thr68 phosphorylation and delayed Ser19 phosphorylation, but did not induce Ser33/35 phosphorylation.

Conclusions:

• Chk2 is involved in the early stages of the DNA damage response.
• Differential phosphorylation kinetics of Chk2 residues suggest DNA damage-specific regulation of Chk2 interactions and activity.
• ATM plays a critical role in mediating Chk2 phosphorylation in response to specific DNA damage.